Drugdiscovery >> Clinical Trials >> News
7846
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung - drugdiscovery.com
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung - drugdiscovery.com


Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung, achieving the primary objective of the trial.
Read More >>


Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech - September 10, 2013
Related Articles
20070
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

7190
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

17255
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

3427
Views
Experimental durg of  Pfizer gives promising results in prevention of community acquired pneumonia Experimental durg of Pfizer gives promising results in prevention of community acquired pneumonia
Pfizer has just finished its landmark stuy over a pnemonia drug. The trial which is based on over 85,000 samples and the new treatment seems to be very effective on patient 65 years and over. Read More >>

Tags: drug; discovery, development, news, Pfizer, CAPITA, clinical trial, CAP, pneumonia, primary endpoint

5059
Views
Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial
According to the results of Phase 2 clnical trial, Humira induced a significant response rate, compared to placebo, in adult patients with moderate-to-severe hidradenitis suppurativa (HS). The drug Read More >>

Tags: Humira, AbbVie, hidradenitis suppurativa, clinical trial

4516
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

6903
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

5674
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

3966
Views
GSK has ended the trials of its new lung cancer treatment GSK has ended the trials of its new lung cancer treatment
Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer. Read More >>

Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development

4164
Views
Merck continues the clinical development of tecemotide for lung cancer Merck continues the clinical development of tecemotide for lung cancer
Tecemotide (also known as L-BLP25), an investigational MUC1 antigen-specific cancer immunotherapy will be tested in a new Phase 3 trial called START for patients with unresectable, locally advanced S Read More >>

Tags: Merck, tecemotide, lung cancer, non-small cell lung cancer, immunotherapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013